المؤلفون: Gregson, J.M., Freitag, D.F., Surendran, P., Stitziel, N.O., Chowdhury, R., Burgess, S., Kaptoge, S., Gao, P., Staley, J.R., Willeit, P., Nielsen, S.F., Caslake, M., Trompet, S., Polfus, L.M., Kuulasmaa, K., Kontto, J., Perola, M., Blankenberg, S., Veronesi, G., Gianfagna, F., Männistö, S., Kimura, A., Lin, H., Reilly, D.F., Gorski, M., Mijatovic, V., Munroe, P.B., Ehret, G.B., Thompson, A., Uria-Nickelsen, M., Malarstig, A., Dehghan, A., Vogt, T.F., Sasaoka, T., Takeuchi, F., Kato, N., Yamada, Y., Kee, F., Müller-Nurasyid, M., Ferrières, J., Arveiler, D., Amouyel, P., Salomaa, V., Boerwinkle, E., Thompson, S.G., Ford, I., Wouter Jukema, J., Sattar, N., Packard, C.J., Shafi Majumder, A.A., Alam, D.S., Deloukas, P., Schunkert, H., Samani, N.J., Kathiresan, S., Nordestgaard, B.G., Saleheen, D., Howson, J.M., Di Angelantonio, E., Butterworth, A.S., Danesh, J.

المساهمون: CKDGen consortium, International Consortium for Blood Pressure, CHARGE inflammation working group, MICAD Exome consortium, EPIC-CVD consortium and the CHD Exome+ consortium

المصدر: European journal of preventive cardiology, vol. 24, no. 5, pp. 492-504

مصطلحات موضوعية: 1-Alkyl-2-acetylglycerophosphocholine Esterase/drug effects, 1-Alkyl-2-acetylglycerophosphocholine Esterase/genetics, Adult, Aged, Alleles, Benzaldehydes/therapeutic use, Case-Control Studies, Coronary Disease/diagnosis, Coronary Disease/drug therapy, Coronary Disease/genetics, Female, Gene Expression Regulation, Genotype, Humans, Male, Middle Aged, Molecular Targeted Therapy, Oximes/therapeutic use, Phospholipase A2 Inhibitors/therapeutic use, Polymorphism, Single Nucleotide, Randomized Controlled Trials as Topic, Reference Values, Reproducibility of Results, Risk Assessment, Treatment Outcome, Human genetics, coronary heart disease, darapladib, lipoprotein-associated phospholipase A2

وصف الملف: application/pdf

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/27940953; info:eu-repo/semantics/altIdentifier/eissn/2047-4881; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_4856BCF7E2789; https://serval.unil.ch/notice/serval:BIB_4856BCF7E278Test; urn:issn:2047-4873; https://serval.unil.ch/resource/serval:BIB_4856BCF7E278.P001/REF.pdfTest; http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_4856BCF7E2789Test

الإتاحة: https://doi.org/10.1177/2047487316682186Test
https://serval.unil.ch/notice/serval:BIB_4856BCF7E278Test
https://serval.unil.ch/resource/serval:BIB_4856BCF7E278.P001/REF.pdfTest
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_4856BCF7E2789Test

المؤلفون: Fruchart, J.C., Santos, R.D., Aguilar-Salinas, C., Aikawa, M., Al Rasadi, K., Amarenco, P., Barter, P.J., Ceska, R., Corsini, A., Després, J.P., Duriez, P., Eckel, R.H., Ezhov, M.V., Farnier, M., Ginsberg, H.N., Hermans, M.P., Ishibashi, S., Karpe, F., Kodama, T., Koenig, W., Krempf, M., Lim, S., Lorenzatti, A.J., McPherson, R., Nuñez-Cortes, J.M., Nordestgaard, B.G., Ogawa, H., Packard, C.J., Plutzky, J., Ponte-Negretti, C.I., Pradhan, A., Ray, K.K., Reiner, Ž., Ridker, P.M., Ruscica, M., Sadikot, S., Shimano, H., Sritara, P., Stock, J.K., Su, T.C., Susekov, A.V., Tartar, A., Taskinen, M.R., Tenenbaum, A., Tokgözoğlu, L.S., Tomlinson, B., Tybjærg-Hansen, A., Valensi, P., Vrablík, M., Wahli, W., Watts, G.F., Yamashita, S., Yokote, K., Zambon, A., Libby, P.

المصدر: Cardiovascular diabetology, vol. 18, no. 1, pp. 71

مصطلحات موضوعية: Animals, Benzoxazoles/adverse effects, Benzoxazoles/therapeutic use, Biomarkers/blood, Butyrates/adverse effects, Butyrates/therapeutic use, Cardiovascular Diseases/blood, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/prevention & control, Consensus, Dyslipidemias/blood, Dyslipidemias/diagnosis, Dyslipidemias/drug therapy, Humans, Hypolipidemic Agents/adverse effects, Hypolipidemic Agents/therapeutic use, Lipids/blood, Molecular Targeted Therapy, PPAR alpha/agonists, PPAR alpha/metabolism, Patient Safety, Risk Assessment, Risk Factors, Signal Transduction, Treatment Outcome, Atherogenic dyslipidemia, Diabetes, Inflammation, PROMINENT, Pemafibrate (K-877), Remnant cholesterol, Residual cardiovascular risk, SPPARMalpha, Selective peroxisome proliferator-activated receptor alpha modulator, Triglycerides, Visceral obesity

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=od______1900::1e42e4b07a96300e14b1450540aec81bTest
https://serval.unil.ch/resource/serval:BIB_A62033B5071E.P001/REF.pdfTest

المؤلفون: Welsh, P., Murray, H.M., Ford, I., Trompet, S., Craen, A.J.M. de, Jukema, J.W., Stott, D.J., McInnes, I.B., Packard, C.J., Westendorp, R.G.J., Sattar, N., PROSPER Study Grp

المصدر: Arteriosclerosis, Thrombosis, and Vascular Biology, 31(10), 2338

مصطلحات موضوعية: Male, cardiovascular disease prevention cytokines epidemiology risk factors inflammation coronary-heart-disease c-reactive protein antiinflammatory cytokine interleukin-10 unstable angina artery-disease atherosclerosis mice inflammation serum pravastatin, medicine.medical_specialty, Aging, Time Factors, Risk Assessment, Risk Factors, Internal medicine, Epidemiology, medicine, Odds Ratio, Humans, Prospective Studies, Prospective cohort study, Aged, Pravastatin, Proportional Hazards Models, Aged, 80 and over, Proportional hazards model, business.industry, Case-control study, Age Factors, Odds ratio, Interleukin-10, Logistic Models, Cardiovascular Diseases, Case-Control Studies, Cohort, Female, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Cardiology and Cardiovascular Medicine, business, Risk assessment, Biomarkers, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d10e1b83c955532d966f80a429b0b44Test
http://hdl.handle.net/1887/116701Test